Author
DO, RON - Massachusetts General Hospital | |
WILLER, CRISTEN - University Of Michigan | |
SCHMIDT, ELLEN - University Of Michigan | |
SENGUPTA, SEBANTI - University Of Michigan | |
GAO, CHI - Massachusetts General Hospital | |
PELOSO, GINA - Massachusetts General Hospital | |
GUSTAFSSON, STEGAN - Uppsala University | |
KANONI, STAVROULA - Wellcome Trust Sanger Institute | |
GANNA, ANDREA - Uppsala University | |
CHEN, JIN - University Of Michigan | |
BUCHKOVICH, MARTIN - University Of North Carolina | |
MORA, SAMIA - Brigham & Women'S Hospital | |
BECKMANN, JACQUES - Lausanne University Hospital | |
BRAGG-GRESHAM, JENNIFER - University Of Michigan | |
CHANG, HSING-YI - Institute Of Population Health Sciences | |
DEMIRKAN, AYSE - Erasmus Medical Center | |
DEN HERTOG, HELEEN - Erasmus Medical Center | |
DONNELLY, LOUISE - University Of Dundee | |
EHRET, GEORG - Geneva University Hospital | |
ESKO, TONU - Broad Institute Of Mit/harvard | |
FEITOSA, MARY - Washington University | |
FERREIRA, TERESA - University Of Oxford | |
FISCHER, KRISTA - University Of Tartu | |
FONTANILLAS, PIERRE - Broad Institute Of Mit/harvard | |
FRASER, ROSS - University Of Edinburgh | |
FREITAG, DANIEL - University Of Cambridge | |
GURDASANI, DEEPTI - Wellcome Trust Sanger Institute | |
HEIKKILÄ, KAUKO - University Of Helsinki | |
HYPPÖNEN, ELINA - University College London | |
ISAACS, AARON - Erasmus Medical Center | |
JACKSON, ANNE - University Of Michigan | |
JOHANSSON, ASA - Uppsala University | |
JOHNSON, TOBY - Queen Mary University Of London | |
KAAKINEN, MARIKA - University Of Oulu | |
KETTUNEN, JOHANNES - University Of Helsinki | |
KLEBER, MARCUS - University Of Ulm Medical Center | |
LI, XIAOHUI - Cedars-Sinai Medical Center | |
LUAN, JIAN'AN - Addenbrooke'S Hospital | |
LYYTIKÄINEN, LEO-PEKKA - Fimlab Laboratories | |
MAGNUSSON, PATRIK K E - Karolinska Institute | |
MANGINO, MASSIMO - King'S College | |
MIHAILOV, EVELIN - University Of Tartu | |
MONTASSER, MARY - University Of Maryland | |
MÜLLER-NURASYID, MARTINA - Ludwig-Maximilians University | |
NOLTE, LLJM - University Of Groningen | |
O'CONNELL, JEFFREY - University Of Maryland | |
PALMER, CAMERON - Broad Institute Of Mit/harvard | |
PEROLA, MARKUS - University Of Tartu | |
PETERSEN, ANN-KRISTIN - German Research Center For Environmental Health | |
SANNA, SERENA - Instituto Di Ricerca Genetica E Biomedica | |
SAXENA, RICHA - Massachusetts General Hospital | |
SERVICE, SUSAN - Ucla Health System | |
SHAH, SONIA - University College London | |
SHUNGIN, DMITRY - Scania University Hospital | |
SIDORE, CARLO - University Of Michigan | |
SONG, CI - Uppsala University | |
STRAWBRIDGE, RONA - Karolinska University Hospital | |
SURAKKA, IDA - University Of Helsinki | |
TANAKA, TOSHIKO - National Institutes Of Health (NIH) | |
TESLOVICH, TANYA - University Of Michigan | |
THORLEIFSSON, GUDMAR - Amgen, Inc | |
VAN DEN HERIK, EVITA - Erasmus Medical Center | |
VOIGHT, BENJAMIN - University Of Pennsylvania | |
VOLCIK, KELLY - University Of Texas Health Science Center | |
WAITE, LINDSAY - Hudsonalpha Institute For Biotechnology | |
WONG, ANDREW - University College London | |
WU, YING - University Of North Carolina | |
ZHANG, WEIHUA - Imperial College | |
ABSHER, DEVIN - Hudsonalpha Institute For Biotechnology | |
ASIKI, GERSHIM - Uganda Virus Research Institute | |
BARROSO, INES - Wellcome Trust Sanger Institute | |
BEEN, LATONYA - University Of Oklahoma | |
BOLTON, JENNIFER - University Of Edinburgh | |
BONNYCASTLE, LORI - National Institutes Of Health (NIH) | |
BRAMBILLA, PAOLO - University Of Milano | |
BURNETT, MARY - Medstar Research Institute | |
CESANA, GIANCARLO - University Of Milano | |
DIMITRIOUS, MARIA - Harokopio University Of Athens | |
DONEY, ALEX S - University Of Dundee | |
DORING, ANGELA - German Research Center For Environmental Health | |
ELLIOTT, PAUL - University Of Oulu | |
EPSTEIN, STEPHEN - Medstar Research Institute | |
EYJOLFSSON, GUDMUNDUR INGI - Icelandic Medical Center | |
GIGANTE, BRUNA - Karolinska Institute | |
GOODARZI, MARK - Cedars-Sinai Medical Center | |
GRALLERT, HARALD - Helmholtz Centre | |
GRAVITO, MARTHA - University Of Oklahoma | |
GROVES, CHRISTPHER - University Of Oxford | |
HALLMANS, GORAN - University Of Umea | |
HARTIKAINEN, ANNA LIISA - University Of Oulu | |
HAYWARD, CAROLINE - Western General Hospital | |
HERNANDEZ, DENA - National Institute On Aging (NIA, NIH) | |
HICKS, ANDREW - Institute Of Population Health Sciences | |
HOLM, HILMA - Amgen, Inc | |
HUNG, YI-JEN - Tri-Service General Hospital | |
ILLIG, THOMAS - Helmholtz Centre | |
JONES, MICHELLE - Cedars-Sinai Medical Center | |
KALEEBU, PONTINAO - Uganda Virus Research Institute | |
ORDOVAS, JOSE - Jean Mayer Human Nutrition Research Center On Aging At Tufts University |
Submitted to: Nature Genetics
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 9/13/2013 Publication Date: 10/6/2013 Citation: Do, R., Willer, C.J., Schmidt, E.M., Sengupta, S., Gao, C., Peloso, G.M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., Buchkovich, M.L., Mora, S., Beckmann, J.S., Bragg-Gresham, J.L., Chang, H., Demirkan, A., Den Hertog, H.M., Donnelly, L.A., Ehret, G.B., Esko, T., Feitosa, M.F., Ferreira, T., Fischer, K., Fontanillas, P., Fraser, R.M., Freitag, D.F., Gurdasani, D., Heikkilä, K., Hyppönen, E., Isaacs, A. 2013. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature Genetics. 45(11):1345-1352. DOI: 10.1038/NG.2795. Interpretive Summary: Triglycerides are transported in blood by specific triglyceride-rich lipoproteins; in epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery disease (CAD). However, it is unclear whether this association is causative or the result of the correlation of triglyceride levels with other CAD risk factors. In order to answer this question, we used 185 common genetic variants recently identified for blood lipids to examine the direct role of triglycerides in risk for CAD. First, we focused on genes associated with both low-density lipoprotein cholesterol (LDL-C) and triglyceride levels, and we showed that they both are positively associated with CAD risk. Second, we considered genes exclusively associated with triglycerides and showed that these genes were also associated with CAD. Finally, when we accounted for effects on LDL-C and/or high-density lipoprotein cholesterol (HDL-C) levels, the strength of a polymorphism's effect on triglyceride levels is correlated with the magnitude of its effect on CAD risk. These results support that triglyceride-rich lipoproteins causally influence risk for CAD. Therefore, they should be considered as primary targets for CAD risk modification and disease prevention. Technical Abstract: Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery disease (CAD). However, it is unclear whether this association reflects causal processes. We used 185 common variants recently mapped for plasma lipids (P < 5 × 10(-8) for each) to examine the role of triglycerides in risk for CAD. First, we highlight loci associated with both low-density lipoprotein cholesterol (LDL-C) and triglyceride levels, and we show that the direction and magnitude of the associations with both traits are factors in determining CAD risk. Second, we consider loci with only a strong association with triglycerides and show that these loci are also associated with CAD. Finally, in a model accounting for effects on LDL-C and/or high-density lipoprotein cholesterol (HDL-C) levels, the strength of a polymorphism's effect on triglyceride levels is correlated with the magnitude of its effect on CAD risk. These results suggest that triglyceride-rich lipoproteins causally influence risk for CAD. |